[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU84102A - Nova dibenzoazulen jedinjenja kao inhibitori faktora nekroze tumora - Google Patents

Nova dibenzoazulen jedinjenja kao inhibitori faktora nekroze tumora

Info

Publication number
YU84102A
YU84102A YU84102A YUP84102A YU84102A YU 84102 A YU84102 A YU 84102A YU 84102 A YU84102 A YU 84102A YU P84102 A YUP84102 A YU P84102A YU 84102 A YU84102 A YU 84102A
Authority
YU
Yugoslavia
Prior art keywords
necrosis factor
tumor necrosis
new
compounds
factor inhibitors
Prior art date
Application number
YU84102A
Other languages
English (en)
Inventor
Mladen Merćep
Milan MESIĆ
Dijana Pešić
Željko Županović
Boška Hrvačić
Original Assignee
Pliva Farmaceutska Industrija D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska Industrija D.D. filed Critical Pliva Farmaceutska Industrija D.D.
Publication of YU84102A publication Critical patent/YU84102A/sh
Publication of RS50893B publication Critical patent/RS50893B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Ovaj se pronalazak odnosi na dibenzoazulenska jedinjenja prikazana formulom I, kao i na njihove farmaceutske preparate za inhibiranje faktora alfa tumorske nekroze (TNF-α) i interleukina-1 (IL-1) kod sisara, za sva oboljenja i stanja u kojima je preterana sekrecija ovih medijatora. Jedinjenja prema ovom pronalasku pokazuju takodje i analgetsko dejstvo pa mogu da budu upotrebljena za otklanjanje bola.[The present invention relates to the dibenzoazulene compounds represented by formula I as well as to their pharmaceutical preparations for the inhibition of tumor necrosis factor alpha (TNF-α) and interleukine 1 (IL-1) in mammals at all diseases and conditions where these mediators are excessively secreted. The compounds of the present invention also demonstrate an analgetic action and can be used to relieve pain.
YUP-841/02A 2000-05-17 2001-05-16 Nova dibenzoazulen jedinjenja kao inhibitori faktora nekroze tumora RS50893B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR20000310A HRP20000310A2 (en) 2000-05-17 2000-05-17 New dibenzoazulene compounds as tumor necrosis factor inhibitors

Publications (2)

Publication Number Publication Date
YU84102A true YU84102A (sh) 2006-01-16
RS50893B RS50893B (sr) 2010-08-31

Family

ID=10947110

Country Status (37)

Country Link
US (2) US6897211B2 (sh)
EP (1) EP1284977B1 (sh)
JP (1) JP2003533528A (sh)
KR (1) KR100823064B1 (sh)
CN (1) CN1194976C (sh)
AR (1) AR030562A1 (sh)
AT (1) ATE434619T1 (sh)
AU (2) AU2001256560B2 (sh)
BG (1) BG65967B1 (sh)
BR (1) BR0111202A (sh)
CA (1) CA2409090C (sh)
CR (1) CR6860A (sh)
CY (1) CY1109328T1 (sh)
CZ (1) CZ301770B6 (sh)
DE (1) DE60139070D1 (sh)
DK (1) DK1284977T3 (sh)
DZ (1) DZ3357A1 (sh)
EA (1) EA006069B1 (sh)
EE (1) EE200200636A (sh)
ES (1) ES2328335T3 (sh)
GE (1) GEP20043304B (sh)
HK (1) HK1056719A1 (sh)
HR (1) HRP20000310A2 (sh)
HU (1) HUP0302295A3 (sh)
IL (1) IL152809A0 (sh)
IS (1) IS6621A (sh)
MA (1) MA27125A1 (sh)
MX (1) MXPA02011269A (sh)
NO (1) NO20025510L (sh)
NZ (1) NZ522553A (sh)
PL (1) PL204849B1 (sh)
PT (1) PT1284977E (sh)
RS (1) RS50893B (sh)
SI (1) SI1284977T1 (sh)
SK (1) SK17702002A3 (sh)
WO (1) WO2001087890A1 (sh)
ZA (1) ZA200209180B (sh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020304B1 (en) * 2002-04-10 2008-04-30 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof
HRP20020303A8 (en) * 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. Benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020305A8 (en) 2002-04-10 2009-03-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
HRP20020441A2 (en) * 2002-05-21 2003-12-31 Pliva D D 1-oxa-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020440B1 (en) * 2002-05-21 2008-02-29 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
HRP20020453A2 (en) 2002-05-23 2003-12-31 Pliva D D 1,3-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediate for preparation thereof
HRP20020452A2 (en) 2002-05-23 2004-02-29 Pliva D D 1,2-diaza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20020451A2 (en) * 2002-05-23 2003-12-31 Pliva D D 1-tia-3-aza-dibenzoazulen as inhibitor of production of tumor necrosis factors and intermediates for preparation thereof
HRP20030160A2 (en) * 2003-03-06 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. 1-thiadibenzoazulene derivatives and biological action thereof
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
EP1706394B1 (en) * 2003-11-12 2014-12-17 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
HRP20030955A2 (en) * 2003-11-21 2005-08-31 Pliva-Istra�iva�ki institut d.o.o. USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030954A2 (en) * 2003-11-21 2005-08-31 Pliva D.D. USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20040104A2 (en) * 2004-01-30 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
ES2337915T3 (es) 2004-10-27 2010-04-30 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Conjugados con adtividad antiinflamatoria.
JP4912320B2 (ja) * 2004-12-07 2012-04-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 置換された四環式テトラヒドロピラン、ピロリジンおよびテトラヒドロチオフェン誘導体
JP2008532927A (ja) * 2005-01-13 2008-08-21 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 抗炎症マクロライド接合体
JP2009529057A (ja) 2006-03-08 2009-08-13 コートリア・コーポレーシヨン Ｃｏｘ−関連胃損傷を予防するための非−選択的ｃｏｘ阻害剤との組み合わせ療法
WO2008094275A1 (en) 2007-01-30 2008-08-07 New York University Peptides for treatment of conditions associated with nitric oxide
WO2008096755A1 (ja) * 2007-02-07 2008-08-14 Nippon Suisan Kaisha, Ltd. バニロイド受容体（ｖｒ１）阻害剤及びその用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3711489A (en) * 1971-03-31 1973-01-16 Pfizer Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles
JPS53116385A (en) * 1977-03-19 1978-10-11 Hokuriku Pharmaceutical Pyrazin derivative and method for its production
US4198421A (en) * 1978-11-30 1980-04-15 E. I. Du Pont De Nemours And Company Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
PL190960B1 (pl) * 1996-04-12 2006-02-28 Janssen Pharmaceutica Nv Tetracykliczna pochodna tetrahydrofuranu, kompozycja farmaceutyczna i sposób wytwarzania tetracyklicznej pochodnej tetrahydrofuranu
GB9713368D0 (en) * 1997-06-25 1997-08-27 Weston Medical Ltd Flame control
EP0887339A1 (de) * 1997-06-27 1998-12-30 Roche Diagnostics GmbH Neue Azulenderivate und diese enthaltende Arzneimittel

Also Published As

Publication number Publication date
AU5656001A (en) 2001-11-26
BG65967B1 (bg) 2010-07-30
US20050171091A1 (en) 2005-08-04
PT1284977E (pt) 2009-09-09
IS6621A (is) 2002-11-14
MXPA02011269A (es) 2003-06-06
EE200200636A (et) 2004-04-15
BR0111202A (pt) 2003-04-01
EP1284977A1 (en) 2003-02-26
AU2001256560B2 (en) 2005-10-06
JP2003533528A (ja) 2003-11-11
RS50893B (sr) 2010-08-31
GEP20043304B (en) 2004-02-10
CZ301770B6 (cs) 2010-06-16
SI1284977T1 (sl) 2009-10-31
EA200201223A1 (ru) 2003-06-26
HUP0302295A2 (hu) 2003-10-28
DZ3357A1 (fr) 2001-11-22
DK1284977T3 (da) 2009-09-14
ATE434619T1 (de) 2009-07-15
CZ20024090A3 (cs) 2003-05-14
NO20025510D0 (no) 2002-11-15
KR20030010625A (ko) 2003-02-05
NZ522553A (en) 2005-04-29
ES2328335T3 (es) 2009-11-12
CA2409090C (en) 2010-06-29
HRP20000310A2 (en) 2002-02-28
CY1109328T1 (el) 2012-05-23
US6897211B2 (en) 2005-05-24
CA2409090A1 (en) 2001-11-22
PL365054A1 (en) 2004-12-27
ZA200209180B (en) 2003-11-12
HUP0302295A3 (en) 2007-03-28
BG107399A (bg) 2003-09-30
CR6860A (es) 2008-06-02
WO2001087890A1 (en) 2001-11-22
MA27125A1 (fr) 2005-01-03
US20030153750A1 (en) 2003-08-14
SK17702002A3 (sk) 2003-10-07
DE60139070D1 (de) 2009-08-06
IL152809A0 (en) 2003-06-24
AR030562A1 (es) 2003-08-27
NO20025510L (no) 2003-01-14
KR100823064B1 (ko) 2008-04-18
EA006069B1 (ru) 2005-08-25
PL204849B1 (pl) 2010-02-26
EP1284977B1 (en) 2009-06-24
HK1056719A1 (en) 2004-02-27
CN1194976C (zh) 2005-03-30
CN1437605A (zh) 2003-08-20

Similar Documents

Publication Publication Date Title
YU84102A (sh) Nova dibenzoazulen jedinjenja kao inhibitori faktora nekroze tumora
HK1057899A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
HK1087702A1 (en) Arylmethylamine derivatives for use as tryptase inhibitors
BG105653A (en) Aromatic heterocyclic compounds as anti-inflammatory agents
BG106406A (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
TW200510328A (en) 5-membered heterocycle-based p38 kinase inhibitors
HK1012623A1 (en) Pyrimidinyl derivatives as interleukin inhibitors.
WO2002002520A3 (en) Compounds to treat alzheimer's disease
MX9803851A (es) Compuestos macrociclicos novedosos como inhibidores de metaloproteasas.
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
WO1999009000A3 (en) Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis
ATE415965T1 (de) Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung
AU7385398A (en) Novel macrocyclic compounds as metalloprotease inhibitors
ITMI20042475A1 (it) Uso di derivati tiazolidinonici come agenti terapeutici
NO972906D0 (no) 4,4-(Disubstituerte)cykloheksan-1-ol-monomerer og beslektede forbindelser
SE9802207D0 (sv) Novel compounds
MX9704740A (es) Monomeros de 3,3-(disustituido)ciclohexan-1-ol y compuestos relacionados.
TNSN05307A1 (en) 5-membered heterocycle-based p38 kinase inhibitors